Korea Q3 Results Roundup: Lazertinib Boosts Yuhan, Hanmi Dispute Simmers

 
• By Jung Won Shin
  
third quarter
Yuhan Unveils Strategy To Find Next Potential Global Blockbusters (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Strategy